Market Research Logo

United Kingdom Neurostimulation Devices Market Outlook to 2023

United Kingdom Neurostimulation Devices Market Outlook to 2023

Summary

GlobalData’s new report, United Kingdom Neurostimulation Devices Market Outlook to 2023, provides key market data on the United Kingdom Neurostimulation Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Cortical Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Neurostimulation Devices market segments - Cortical Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United Kingdom Neurostimulation Devices market.
  • Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurostimulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurostimulation Devices Market, United Kingdom
3.1 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2009-2016
3.2 Neurostimulation Devices Market, United Kingdom, Revenue ($m), 2016-2023
3.3 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2009-2016
3.4 Neurostimulation Devices Market, United Kingdom, Volume (Units), 2016-2023
3.5 Neurostimulation Devices Market, United Kingdom, Average Price ($), 2009-2023
3.6 Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2015-2016
3.7 Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United Kingdom, Neurostimulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 St. Jude Medical LLC
4.2.1 Company Overview
4.3 LivaNova PLC
4.3.1 Company Overview
4.4 Boston Scientific Corp
4.4.1 Company Overview
4.5 Integra LifeSciences Holdings Corp
4.5.1 Company Overview
5 Neurostimulation Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Nestle Health Science to Acquire Phagenesis
7 Recent Developments
7.1 Corporate Communications
7.1.1 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation
7.1.2 Feb 01, 2017: Sanofi Appoints Hugo Fry as General Manager UK
7.1.3 Jan 19, 2017: Abbas Hussain to leave GSK
7.1.4 Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK
7.1.5 Dec 19, 2016: GSK announces Board changes
7.1.6 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester
7.1.7 Oct 14, 2016: AorTech International Announces Board Changes
7.1.8 Sep 29, 2016: GlaxoSmithKline appoints Brian McNamara as CEO of GSK Consumer Healthcare
7.1.9 Sep 20, 2016: Emma Walmsley to succeed Andrew Witty as Chief Executive Officer of GlaxoSmithKline
7.1.10 Aug 01, 2016: LivaNova Names Chief Operating Officer
7.1.11 Jul 28, 2016: LivaNova Names Andrea L. Saia to its Board of Directors
7.1.12 Jul 07, 2016: GSK and Save the Children call for developing country innovations to enter $1 million award
7.1.13 Jun 14, 2016: GlaxoSmithKline: Executive Director Change
7.1.14 May 27, 2016: GlaxoSmithKline Announces Board and Committee changes
7.2 Financial Announcements
7.2.1 May 03, 2017: LivaNova Reports First Quarter 2017 Results
7.2.2 Apr 26, 2017: GSK delivers another quarter of continued progress
7.2.3 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance
7.2.4 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results
7.2.5 Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016
7.2.6 Dec 21, 2016: AorTech International: Unaudited Interim Results For the six months ended 30 September 2016
7.2.7 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results
7.2.8 Oct 26, 2016: GlaxoSmithKline: Results Announcement for the third quarter 2016
7.2.9 Sep 29, 2016: LivaNova Announces Half-Year Financial Report
7.2.10 Aug 15, 2016: AorTech International: Audited results for the year ended 31 March 2016
7.2.11 Aug 03, 2016: LivaNova Reports Second Quarter 2016 Results
7.2.12 Jul 27, 2016: GlaxoSmithKline: Results announcement for the second quarter 2016 and half-yearly financial report for the half-year 2016
7.3 Legal And Regulatory
7.3.1 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange
7.3.2 Dec 21, 2016: AorTech Shares Dive As Losses And Lawsuit Against Former CEO Continue
7.4 Other Significant Developments
7.4.1 Dec 13, 2016: Magstim announces new distribution partnership in Netherlands
7.4.2 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction
7.4.3 Jul 27, 2016: GSK announces significant new investment in UK manufacturing network
7.5 Strategy And Business Planning
7.5.1 Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
7.5.2 Jul 06, 2016: LivaNova Sets Operating Model and Supporting Organization
7.5.3 May 20, 2016: Avalon Ventures and COI Pharmaceuticals Announce First Milestones for Sitari Pharmaceuticals and Silarus Therapeutics and Formation of Eighth Company
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Table 4: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Table 5: Neurostimulation Devices Market, United Kingdom, Average Price ($), Historic, 2009-2016
Table 6: Neurostimulation Devices Market, United Kingdom, Average Price ($), Forecast, 2016-2023
Table 7: Neurostimulation Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 8: Neurostimulation Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2016
Table 9: Neurostimulation Devices Market Pipeline Products
Table 10: Nestle Health Science to Acquire Phagenesis
1.2 List of Figures
Figure 1: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Neurostimulation Devices Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Neurostimulation Devices Market, United Kingdom, Volume (Units), Historic, 2009-2016
Figure 4: Neurostimulation Devices Market, United Kingdom, Volume (Units), Forecast, 2016-2023
Figure 5: Neurostimulation Devices Market, United Kingdom, Company Share (%) 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report